Food News and Research

RSS

Some employers continue to offer 'skinny' plans

Even though the Obama administration will not enforce the mandate requiring large employers to offer coverage for another year, some companies still plan to offer so-called "skinny," or limited benefit plans -- and the federal government will permit them, according to Politico. Other reports look at the growth in part-time jobs and whether that is a result of the health care law.

17 Jul 2013

Women who gain weight during pregnancy are more likely to give birth to heavier babies

Moms-to-be who gain too much weight early into their pregnancy are nearly three times as likely to give birth to bigger and fatter babies, warns a University of Alberta researcher.

17 Jul 2013

Vitamin and mineral supplements can enhance mental energy and well-being

Vitamin and mineral supplements can enhance mental energy and well-being not only for healthy adults but for those prone to anxiety and depression, according to a July 15 panel discussion at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo- held at McCormick Place.

17 Jul 2013

Healthy snacks that promote satiety may limit overall food consumption

Healthy snacks that promote a feeling of fullness (satiety) may reduce the amount of food intake at subsequent meals and limit overall food consumption, according to a presentation today at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo in Chicago.

17 Jul 2013

Adding small amount of spices to meals may help Americans cut down on dietary fat

...

17 Jul 2013

OncoGenex completes enrollment in OGX-427 Phase 2 trial for treatment of metastatic bladder cancer

OncoGenex Pharmaceuticals, Inc. today announced that enrollment has been completed in Borealis-1, a company-sponsored, randomized, placebo-controlled Phase 2 trial of OGX-427 in combination with first-line gemcitabine and cisplatin in patients with metastatic bladder cancer.

16 Jul 2013

FDA accepts Iroko's submicron indomethacin NDA for treatment of acute pain in adults

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.

16 Jul 2013

New Mexico Medicaid overhaul OK'd

Medicaid recipients will face co-pays for some treatments and have their medical services tracked as part of a program overhaul that is intended to lower the costs of providing health care, Gov. Susana Martinez's administration announced Monday. There will be no changes in determining who qualifies for Medicaid, which serves about a quarter of New Mexico's population (Massey, 7/15).

16 Jul 2013

Misonix gets clearance to market BoneScalpel product in China

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced today that Misonix has received the necessary Registration Certificate from the State Food and Drug Administration of the People's Republic of China to market and sell its BoneScalpel (Ultrasonic Osteotome System) product in China.

16 Jul 2013

Qualigen's FastPack Vitamin D Immunoassay receives FDA clearance

Qualigen, Inc., a privately owned company that provides rapid, easy to use, fully quantitative diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration for its FastPack Vitamin D Immunoassay for use on its proprietary FastPack System for the rapid determination of vitamin D status.

16 Jul 2013

Researchers develop new test to detect E. coli at food processing facilities

Medical, agriculture and computer science researchers from the University of Alberta have teamed up to develop a test that will make Canadians feel safer about the meat they put on their tables.

16 Jul 2013

Actavis’ Lamictal ODT drug receives FDA approval for treatment of epilepsy and bipolar disorder

Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.

16 Jul 2013

CUMC researchers develop new approach to tailor cancer therapy for individual patient

Columbia University Medical Center (CUMC) researchers are developing a new approach to cancer clinical trials, in which therapies are designed and tested one patient at a time.

16 Jul 2013

Study shows link between FTO, ghrelin and impaired brain food-cue responsivity

Individuals carrying the "obesity-risk" allele of the fat mass and obesity associated gene, FTO, are prone to obesity and obesity related eating behaviors such as increased food consumption, preference for high fat foods and lack of satiation after eating.

16 Jul 2013

Furiex Pharmaceuticals enrolls patient for Phase III clinical trial of eluxadoline for treatment of diarrhea

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced completion of patient enrollment in the company's two ongoing Phase III clinical trials studying eluxadoline for the treatment of diarrhea-predominant irritable bowel syndrome, or IBS-d. Both studies met their target enrollments and Furiex expects to release top line results in the first quarter of 2014.

16 Jul 2013

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.

16 Jul 2013

Coffee and appetite: an interview with Matt Schubert and Associate Professor Ben Desbrow, Griffith University

We wanted to do something a bit different than the “typical” work on caffeine and exercise, and I have considerable interest in appetite regulation, so we built up from there.

15 Jul 2013

Actavis receives FDA approval for Opana ER tablets

Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Oxymorphone Hydrochloride Extended-release Tablets, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg.

15 Jul 2013

FDA approves QIAGEN’s therascreen EGFR test as companion diagnostic for NSCLC patients

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received approval by the U.S. Food and Drug Administration (FDA) to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim's new targeted therapy, GILOTRIF™ (afatinib), for treatment of metastatic NSCLC in patients whose tumors have certain EGFR gene mutations.

From QIAGEN Manchester Limited 15 Jul 2013

Infrared light allows characterization of pathogens

The bacterium Staphylococcus aureus (S. aureus) is commonly found in nature and frequently colonizes the skin and the upper respiratory tract of humans. A healthy immune system can fight the microorganism but once the immune system is weakened the pathogen can spread and lead to life-threatening diseases of the lungs, the heart and other organs.

15 Jul 2013

Food News and Research

Some employers continue to offer 'skinny' plans

Women who gain weight during pregnancy are more likely to give birth to heavier babies

Vitamin and mineral supplements can enhance mental energy and well-being

Healthy snacks that promote satiety may limit overall food consumption

Adding small amount of spices to meals may help Americans cut down on dietary fat

OncoGenex completes enrollment in OGX-427 Phase 2 trial for treatment of metastatic bladder cancer

FDA accepts Iroko's submicron indomethacin NDA for treatment of acute pain in adults

New Mexico Medicaid overhaul OK'd

Misonix gets clearance to market BoneScalpel product in China

Qualigen's FastPack Vitamin D Immunoassay receives FDA clearance

Researchers develop new test to detect E. coli at food processing facilities

Actavis’ Lamictal ODT drug receives FDA approval for treatment of epilepsy and bipolar disorder

CUMC researchers develop new approach to tailor cancer therapy for individual patient

Study shows link between FTO, ghrelin and impaired brain food-cue responsivity

Furiex Pharmaceuticals enrolls patient for Phase III clinical trial of eluxadoline for treatment of diarrhea

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Coffee and appetite: an interview with Matt Schubert and Associate Professor Ben Desbrow, Griffith University

Actavis receives FDA approval for Opana ER tablets

FDA approves QIAGEN’s therascreen EGFR test as companion diagnostic for NSCLC patients

Infrared light allows characterization of pathogens

Understanding cultivated meat and its global potential eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News